We are live on ! Find out more
MFIM

Mesirow Financial Investment Management Portfolio holdings

AUM $6.37B
1-Year Est. Return 23.22%
This Fund
S&P 500
This Quarter Est. Return
+1.03%
1 Year Est. Return
+23.22%
3 Year Est. Return
+69.99%
5 Year Est. Return
+94.22%
10 Year Est. Return
AUM
$5.03B
AUM Growth
-$134M
Cap. Flow
-$146M
Cap. Flow %
-2.89%
Top 10 Hldgs %
37.84%
Holding
630
New
37
Increased
289
Reduced
208
Closed
34

Sector Composition

Rank Sector Weight
1 Financials 15.14%
2 Technology 13.38%
3 Industrials 5.56%
4 Communication Services 5.14%
5 Healthcare 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSPR icon
576
InspireMD
NSPR
$40.3M
$78.9K ﹤0.01%
30,000
BRFH icon
577
Barfresh Food Group
BRFH
$29.4M
$62.9K ﹤0.01%
21,398
KLXE icon
578
KLX Energy Services
KLXE
$35.1M
$49.8K ﹤0.01%
+10,000
New +$52K
ILPT
579
Industrial Logistics Properties Trust
ILPT
$605M
$49.8K ﹤0.01%
13,631
+36
+0.3% +$139
ESPR
580
DELISTED
Esperion Therapeutics
ESPR
$44K ﹤0.01%
20,000
KRMD icon
581
KORU Medical Systems
KRMD
$152M
$42.2K ﹤0.01%
10,959
CMU
582
DELISTED
MFS High Yield Municipal Trust
CMU
$38.9K ﹤0.01%
11,047
+134
+1% +$481
ABEV icon
583
Ambev
ABEV
$43.5B
$35.7K ﹤0.01%
19,301
+4,801
+33% +$10.6K
INTS icon
584
Intensity Therapeutics
INTS
$11.2M
$35.2K ﹤0.01%
800
-967
-55% -$70.2K
MJ icon
585
Amplify Alternative Harvest ETF
MJ
$111M
$32.6K ﹤0.01%
1,213
-115
-9% -$3.85K
LYG icon
586
Lloyds Banking Group
LYG
$89.8B
$31.9K ﹤0.01%
+11,743
New +$33.5K
DOUG icon
587
Douglas Elliman
DOUG
$184M
$30.9K ﹤0.01%
18,500
LIQT icon
588
LiqTech
LIQT
$20M
$25.3K ﹤0.01%
13,754
NEPH icon
589
Nephros
NEPH
$47.4M
$20.3K ﹤0.01%
13,800
TDUP icon
590
ThredUp
TDUP
$405M
$14.9K ﹤0.01%
10,693
VXRT
591
DELISTED
Vaxart
VXRT
$13.2K ﹤0.01%
20,000
-20,000
-50% -$13.9K
SGMO
592
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$12K ﹤0.01%
11,800
LCTX icon
593
Lineage Cell Therapeutics
LCTX
$278M
$10.1K ﹤0.01%
+20,001
New +$14.7K
WBX
594
Wallbox
WBX
$75.7M
$5.01K ﹤0.01%
500
-500
-50% -$7.92K
PIII icon
595
P3 Health Partners
PIII
$38.9M
$3.37K ﹤0.01%
300
ASPN icon
596
Aspen Aerogels
ASPN
$510M
-9,100
Closed -$252K
CCI icon
597
Crown Castle
CCI
$31.5B
-2,032
Closed -$241K
GNR icon
598
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.95B
-3,878
Closed -$224K
HES
599
DELISTED
Hess
HES
-1,577
Closed -$214K
HII icon
600
Huntington Ingalls Industries
HII
$12.9B
-2,002
Closed -$529K

Similar funds

Mesirow Financial Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Mesirow Financial Investment Management held 630 positions worth $5.03B, down 2.6% from $5.17B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Mesirow Financial Investment Management's Q4 2024 filing shows 37 new, 289 increased, 208 reduced and 34 closed positions. Its largest new stake was iShares iBonds Dec 2028 Term Corporate ETF: 261,018 shares worth $6.5M. The largest sale was Vanguard High Dividend Yield ETF, an estimated $69.8M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

  • Mesirow Financial Investment Management's largest Q4 2024 buy was iShares iBonds Dec 2028 Term Corporate ETF: 261,018 shares worth $6.5M.
  • Mesirow Financial Investment Management added most to VanEck Morningstar Wide Moat ETF in Q4 2024, an estimated $82.7M increase.
  • Mesirow Financial Investment Management's biggest Q4 2024 reduction was Vanguard High Dividend Yield ETF, cutting an estimated $69.8M.
  • Mesirow Financial Investment Management fully exited iShares iBonds Dec 2024 Term Treasury ETF in Q4 2024, selling an estimated $13.7M.
  • Mesirow Financial Investment Management's ten largest holdings make up 38% of its $5.03B portfolio in Q4 2024.
  • Mesirow Financial Investment Management opened 37 new positions and closed 34 in Q4 2024.
  • Mesirow Financial Investment Management's portfolio value fell 2.6% quarter-over-quarter to $5.03B.

Based on Mesirow Financial Investment Management's 13F filing for Q4 2024, filed 7 Feb 2025.